Reset filter
Keywords
GIPERTENZIIA ×
Mostra di più Keywords
Sommario
  1. 1. Test clinico
    1. 1.1. Determinazione dell`idoneità
    1. 1.2. Storia medica
    1. 1.3. Esame fisico
    1. 1.4. Punteggio di valutazione
    1. 1.5. Diagnostica Apparativa
    1. 1.6. Laboratorio
    1. 1.7. Patologia / Istologia
    1. 1.8. Consenso
    1. 1.9. Terapia
    1. 1.10. Rapporto operativo
    1. 1.11. Evento avverso
    1. 1.12. Azione supplementare
  2. 2. Documentazione di routine
  3. 3. Registro / studio di coorte
  4. 4. Garanzia di qualità
  5. 5. Dati Standard
  6. 6. Risultato segnalato dal paziente
  7. 7. Specialità mediche
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

414 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility Hypertension NCT01431508

- 20/09/21 - 1 modulo, 2 itemgroups, 23 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3); ODM derived from: https://clinicaltrials.gov/show/NCT01431508

Eligibility Hypertension NCT01145391

- 20/09/21 - 1 modulo, 2 itemgroups, 12 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Trial; ODM derived from: https://clinicaltrials.gov/show/NCT01145391

Eligibility Hypertension NCT01079494

- 20/09/21 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical Pharmacists Role in the Management of Hypertension in Jordan; ODM derived from: https://clinicaltrials.gov/show/NCT01079494

Eligibility Hypertension NCT01167920

- 20/09/21 - 1 modulo, 2 itemgroups, 15 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Virtual Hypertension Clinic; ODM derived from: https://clinicaltrials.gov/show/NCT01167920

Eligibility Hypertension NCT00803634

- 20/09/21 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO); ODM derived from: https://clinicaltrials.gov/show/NCT00803634

Eligibility Hypertension NCT01038895

- 20/09/21 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria; ODM derived from: https://clinicaltrials.gov/show/NCT01038895

Eligibility Hypertension NCT00549536

- 20/09/21 - 1 modulo, 2 itemgroups, 18 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00549536

Eligibility Hypertension NCT00446511

- 20/09/21 - 1 modulo, 2 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00446511

Eligibility Hypertension NCT00435162

- 20/09/21 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00435162

Eligibility Hypertension NCT00433836

- 20/09/21 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00433836

Eligibility Hypertension NCT00853957

- 20/09/21 - 1 modulo, 2 itemgroups, 18 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00853957

Eligibility Hypertension NCT00852787

- 20/09/21 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00852787

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial